Abcam general company news

Note: click here for financial (RNS) news.

Nov-2007

Jeffrey Iliffe appointed as Chief Financial Officer

Nov-2007

Automated system to expand monoclonal production

Nov-2007

CLC bio customized software supports Abcam's monoclonal development capability

Sep-2007

Full preliminary results for year 2006-7

Jul-2007

High throughput lab facility operational

Mar-2007

Over 30,000 products in our catalog

Dec-2006

Japan office opens

Dec-2006

Plans for high throughput lab facilities announced

Sep-2006

Full preliminary results for year 2005-6

Jul-2006

Appointment of Non-Executive Directors

Jun-2006

Winner of Best Newcomer in the UK techMARK mediscience awards

Jun-2006

Trading update for 2005-2006 financial year

May-2006

Better antibodies, faster

May-2006

Linda Cammish appointed Head of Commercial Development

Mar-2006

World's Antibody Gateway refreshed

Feb-2006

Winner of Private Company of the Year, Business Weekly East of England Business Awards 2005

Feb-2006

20,000+ products, 1,300 new lysates, Abpromise stats, Abupdate & news

Feb-2006

2005-6 interim results published

Jan-2006

Fast Abpromise support, free loading control samples, Abupdate & news

Nov-2005

Search filter, conjugated loading controls, Abupdate & news

Oct-2005

£15.25m share placing

Oct-2005

Intention to float

Oct-2005

Extended North America customer service hours

Sep-2005

Top forty position, Sunday Times Microsoft Tech Track

Sep-2004

50th employee hired

Jun-2004

Jim Warwick becomes Managing Director (Abcam Ltd)

Apr-2003

Jim Warwick (Technical Director) becomes full-time

Mar-2003

25th employee hired

Jun-2001

Technical Director appointed

May-2000

10th employee hired

Apr-2000

Finance Director appointed

©1998-2008 Abcam plc. All rights reserved. Abcam plc is incorporated in the UK, its main country of operations is the UK.
Share price and news information on this site is updated dynamically from data feeds. Static content was last updated on 10th December 2007